These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 790287)

  • 1. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
    Shapiro GG; Bamman J; Kanarek P; Bierman CW
    Pediatrics; 1976 Nov; 58(5):740-3. PubMed ID: 790287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbutaline sulfate and isoproterenol sulfate (metered dose aerosols) in the treatment of asthma.
    Kemp JP; Orgel HA; Meltzer EO; Welch MJ
    Ann Allergy; 1983 Oct; 51(4):436-40. PubMed ID: 6354007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral theophylline disposition in cystic fibrosis.
    Georgitis JW; Eigen H; Warner R; Gonzales MA
    Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
    Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
    Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
    Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
    Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
    Nathan RA; Bodman SF; Storms WW; Mingo TS
    Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized terbutaline sulfate in the treatment of bronchospasm.
    Scoggin CH
    Clin Ther; 1984; 6(5):603-12. PubMed ID: 6434183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
    Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.
    Mentore K; Froh DK; de Lange EE; Brookeman JR; Paget-Brown AO; Altes TA
    Acad Radiol; 2005 Nov; 12(11):1423-9. PubMed ID: 16253854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DNase on exercise capacity in cystic fibrosis.
    Barker M; Franke E; Böhle M; Pfannenstiel C; Heimann G
    Pediatr Pulmonol; 2004 Jul; 38(1):70-4. PubMed ID: 15170876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol formulations of terbutaline and isoproterenol in theophylline-stabilized asthmatic patients.
    Pinnas JL; Campbell SC
    Chest; 1984 Dec; 86(6):896-900. PubMed ID: 6389034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Sadoul P; Woolson RF
    Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial.
    Pan SH; Canafax DM; Le CT; Cipolle RJ; Uden DL; Warwick WJ
    Pediatr Pulmonol; 1989; 6(3):172-9. PubMed ID: 2654849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of aerosolized theophylline in relieving bronchospasm.
    Stewart BN; Block AJ
    Chest; 1976 Jun; 69(6):718-21. PubMed ID: 1277888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR; Dull WL; Kasik JE
    JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.